Hamad Medical Corporation
Doha, Baladiyat ad Dawhah, Qatar
Location status: Recruiting
NCT Number: NCT05914779
Specific Aim : The specific aim is to conduct a randomized prospective clinical trial to determine whether no antibiotics in OHCA patients in the ED with very low likelihood of infection is non-inferior to early antibiotic treatment. Hypothesis a: 28-day all-cause mortality will be non-inferior in OHCA patients with very low likelihood of infection who do not receive antibiotic therapy compared with those who receive early antibiotic therapy Hypothesis b: There will be no difference in subsequent incidence of proven infections in the no antibiotics vs, early antibiotics groups Hypothesis c: There will be no difference in the length of ICU stay and overall hospital stay in the early antibiotics vs. no antibiotics groups
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Doha, Baladiyat ad Dawhah, Qatar
Location status: Recruiting
As above
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will be randomized into antibiotics and no antibiotics groups based on inclusion and exclusion criteria
with antibiotics treatment
Time frame: 28-day
Primary outcome measure is 28-day all-cause mortality in persons who receive no antibiotics compared with those who receive early antibiotics in OHCA patients.
Contact information is provided by the study sponsor or research team.
Hamad Medical Corporation
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01904188
Antibiotic Resistance Genes, Bacterial Infections
Lansing, Michigan, United States
View Trial DetailsNCT05993442
Bacterial Infections, Bacterial Infections and Mycoses
Athens, Greece
View Trial DetailsNCT05846399
Anti-bacterial Agents, Arm Injuries
Columbia, Missouri, United States
View Trial DetailsNCT06178822
Bacterial Infections, Bacterial Infections and Mycoses
Almere Stad, Flevoland, Netherlands
View Trial Details